{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:29:56Z","timestamp":1793035796104,"version":"4.5.0"},"reference-count":45,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2010,11,2]],"date-time":"2010-11-02T00:00:00Z","timestamp":1288656000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0013791","type":"journal-article","created":{"date-parts":[[2010,11,2]],"date-time":"2010-11-02T16:20:16Z","timestamp":1288714816000},"page":"e13791","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":18,"title":["p21-Activated Kinases Are Required for Transformation in a Cell-Based Model of Neurofibromatosis Type 2"],"prefix":"10.1371","volume":"5","author":[{"given":"Hoi Yee","family":"Chow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Stepanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Chernoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2010,11,2]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1471-4914(01)01955-4","article-title":"Tumorigenesis in neurofibromatosis: new insights and potential therapies.","volume":"7","author":"N Reed","year":"2001","journal-title":"Trends Mol Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/jmg.37.12.897","article-title":"Neurofibromatosis type 2.","volume":"37","author":"DG Evans","year":"2000","journal-title":"J Med Genet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"10332","DOI":"10.1074\/jbc.M109979200","article-title":"Structural basis for neurofibromatosis type 2. Crystal structure of the merlin FERM domain.","volume":"277","author":"T Shimizu","year":"2002","journal-title":"J Biol Chem"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1083\/jcb.141.7.1589","article-title":"Structural analysis of Drosophila merlin reveals functional domains important for growth control and subcellular localization.","volume":"141","author":"DR LaJeunesse","year":"1998","journal-title":"J Cell Biol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1038\/sj.onc.1201418","article-title":"Interdomain binding mediates tumor growth suppression by the NF2 gene product.","volume":"15","author":"L Sherman","year":"1997","journal-title":"Oncogene"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1534-5807(01)00009-0","article-title":"The Nf2 tumor suppressor, merlin, functions in Rac-dependent signaling.","volume":"1","author":"RJ Shaw","year":"2001","journal-title":"Dev Cell"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1074\/jbc.C100553200","article-title":"p21-activated kinase links Rac\/Cdc42 signaling to merlin.","volume":"277","author":"GH Xiao","year":"2002","journal-title":"J Biol Chem"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"10394","DOI":"10.1074\/jbc.M200083200","article-title":"Merlin phosphorylation by p21-activated kinase 2 and effects of phosphorylation on merlin localization.","volume":"277","author":"JL Kissil","year":"2002","journal-title":"J Biol Chem"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1128\/MCB.22.4.1150-1157.2002","article-title":"The neurofibromatosis type 2 gene product, merlin, reverses the F-actin cytoskeletal defects in primary human Schwannoma cells.","volume":"22","author":"AM Bashour","year":"2002","journal-title":"Mol Cell Biol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1038\/sj.onc.1202141","article-title":"Ruffling membrane, stress fiber, cell spreading and proliferation abnormalities in human Schwannoma cells.","volume":"17","author":"PD Pelton","year":"1998","journal-title":"Oncogene"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S1097-2765(03)00382-4","article-title":"Merlin, the product of the Nf2 tumor suppressor gene, is an inhibitor of the p21-activated kinase, Pak1.","volume":"12","author":"JL Kissil","year":"2003","journal-title":"Mol Cell"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1073\/pnas.0700044104","article-title":"The Nf2 tumor suppressor regulates cell-cell adhesion during tissue fusion.","volume":"104","author":"ME McLaughlin","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1242\/jcs.016121","article-title":"PAK is required for the disruption of E-cadherin adhesion by the small GTPase Rac.","volume":"121","author":"E Lozano","year":"2008","journal-title":"J Cell Sci"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1478-811X-7-23","article-title":"Rac1 activation inhibits E-cadherin-mediated adherens junctions via binding to IQGAP1 in pancreatic carcinoma cells.","volume":"7","author":"B Hage","year":"2009","journal-title":"Cell Commun Signal"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/cm.20172","article-title":"MEK\/ERK regulates adherens junctions and migration through Rac1.","volume":"64","author":"RM Ray","year":"2007","journal-title":"Cell Motil Cytoskeleton"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1083\/jcb.200503165","article-title":"Merlin\/NF-2 mediates contact inhibition of growth by suppressing recruitment of Rac to the plasma membrane.","volume":"171","author":"T Okada","year":"2005","journal-title":"J Cell Biol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1146\/annurev.biochem.72.121801.161742","article-title":"Biology of the p21-Activated Kinases.","volume":"72","author":"GM Bokoch","year":"2003","journal-title":"Annu Rev Biochem"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1042\/BC20070109","article-title":"A tale of two Paks.","volume":"100","author":"LE Arias-Romero","year":"2008","journal-title":"Biol Cell"},{"key":"ref19","article-title":"PAK thread from amoeba to mammals.","author":"A Kumar","year":"2009","journal-title":"J Cell Biochem"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.1242\/jcs.01392","article-title":"The genetics of Pak.","volume":"117","author":"C Hofmann","year":"2004","journal-title":"J Cell Sci"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s10555-008-9168-1","article-title":"Pak protein kinases and their role in cancer.","volume":"28","author":"B Dummler","year":"2009","journal-title":"Cancer Metastasis Rev"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.molcel.2005.08.035","article-title":"The GIT-Associated Kinase PAK Targets to the Centrosome and Regulates Aurora-A.","volume":"20","author":"ZS Zhao","year":"2005","journal-title":"Mol Cell"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"4900","DOI":"10.1038\/onc.2008.131","article-title":"P21-activated kinase is required for mitotic progression and regulates Plk1.","volume":"27","author":"B Maroto","year":"2008","journal-title":"Oncogene"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"4454","DOI":"10.1128\/MCB.17.8.4454","article-title":"Kinase deficient Pak1 mutants inhibit Ras transformation of Rat-1 fibroblasts.","volume":"17","author":"Y Tang","year":"1997","journal-title":"Mol Cell Biol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"5139","DOI":"10.1073\/pnas.95.9.5139","article-title":"A role for Pak protein kinases in Schwann cell transformation.","volume":"95","author":"Y Tang","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/24184","article-title":"The protein kinase Pak3 positively regulates Raf-1 activity through phosphorylation of serine 338.","volume":"396","author":"AJ King","year":"1998","journal-title":"Nature"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"36609","DOI":"10.1074\/jbc.M502306200","article-title":"Role of group A p21-activated kinases in activation of extracellular-regulated kinase by growth factors.","volume":"280","author":"A Beeser","year":"2005","journal-title":"J Biol Chem"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1083\/jcb.200212141","article-title":"PAK1 phosphorylation of MEK1 regulates fibronectin-stimulated MAPK activation.","volume":"162","author":"JK Slack-Davis","year":"2003","journal-title":"J Cell Biol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"6023","DOI":"10.1128\/MCB.22.17.6023-6033.2002","article-title":"Rac-PAK signaling stimulates extracellular signal-regulated kinase (ERK) activation by regulating formation of MEK1-ERK complexes.","volume":"22","author":"S Eblen","year":"2002","journal-title":"Mol Cell Biol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1086\/302812","article-title":"Functional analysis of the Neurofibromatosis Type 2 protein by means of disease-causing point mutations.","volume":"66","author":"RP Stokowski","year":"2000","journal-title":"Am J Hum Genet"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"5990","DOI":"10.1038\/sj.onc.1205693","article-title":"Cellular transformation by a FERM domain mutant of the Nf2 tumor suppressor gene.","volume":"21","author":"KC Johnson","year":"2002","journal-title":"Oncogene"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"7932","DOI":"10.1158\/0008-5472.CAN-08-0866","article-title":"Validation of the p21-activated kinases as targets for inhibition in neurofibromatosis type 2.","volume":"68","author":"C Yi","year":"2008","journal-title":"Cancer Res"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"5236","DOI":"10.1158\/0008-5472.CAN-07-5849","article-title":"Dissecting and targeting the growth factor-dependent and growth factor-independent extracellular signal-regulated kinase pathway in human schwannoma.","volume":"68","author":"S Ammoun","year":"2008","journal-title":"Cancer Res"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1158\/0008-5472.CAN-06-1608","article-title":"Merlin\/neurofibromatosis type 2 suppresses growth by inhibiting the activation of Ras and Rac.","volume":"67","author":"H Morrison","year":"2007","journal-title":"Cancer Res"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nature04856","article-title":"Tumorigenic transformation by CPI-17 through inhibition of a merlin phosphatase.","volume":"442","author":"H Jin","year":"2006","journal-title":"Nature"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"4463","DOI":"10.1073\/pnas.0510651103","article-title":"Mixed-lineage kinase 3 regulates B-Raf through maintenance of the B-Raf\/Raf-1 complex and inhibition by the NF2 tumor suppressor protein.","volume":"103","author":"DN Chadee","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1128\/MCB.01578-08","article-title":"Loss of the tumor suppressor gene NF2, encoding merlin, constitutively activates integrin-dependent mTORC1 signaling.","volume":"29","author":"MA Lopez-Lago","year":"2009","journal-title":"Mol Cell Biol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1128\/MCB.01581-08","article-title":"NF2\/merlin is a novel negative regulator of mTOR complex 1, and activation of mTORC1 is associated with meningioma and schwannoma growth.","volume":"29","author":"MF James","year":"2009","journal-title":"Mol Cell Biol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nn1630","article-title":"Role of p21-activated kinase pathway defects in the cognitive deficits of Alzheimer disease.","volume":"9","author":"L Zhao","year":"2006","journal-title":"Nat Neurosci"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1161\/01.RES.0000014227.76102.5D","article-title":"A dominant-negative p65 PAK peptide inhibits angiogenesis.","volume":"90","author":"WB Kiosses","year":"2002","journal-title":"Circ Res"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.molcel.2010.04.004","article-title":"A functional requirement for PAK1 binding to the KH(2) domain of the fragile X protein-related FXR1.","volume":"38","author":"E Say","year":"2010","journal-title":"Mol Cell"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"15764","DOI":"10.1021\/ja805555a","article-title":"Targeting large kinase active site with rigid, bulky octahedral ruthenium complexes.","volume":"130","author":"J Maksimoska","year":"2008","journal-title":"J Am Chem Soc"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.chembiol.2008.03.005","article-title":"An isoform-selective, small-molecule inhibitor targets the autoregulatory mechanism of p21-activated kinase.","volume":"15","author":"SW Deacon","year":"2008","journal-title":"Chem Biol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.expneurol.2009.04.019","article-title":"PAK kinase regulates Rac GTPase and is a potential target in human schwannomas.","volume":"218","author":"C Flaiz","year":"2009","journal-title":"Exp Neurol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"4328","DOI":"10.1093\/emboj\/17.15.4328","article-title":"PAK promotes morphological changes by acting upstream of Rac.","volume":"17","author":"A Obermeier","year":"1998","journal-title":"EMBO 999J"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0013791","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T18:23:51Z","timestamp":1540319031000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0013791"}},"subtitle":[],"editor":[{"given":"Bill","family":"Hooker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2010,11,2]]},"references-count":45,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2010,11,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0013791","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,2]]}}}